Literature DB >> 32872711

[Recommendations for clinical management of Kawasaki disease with coronary artery lesions (2020 revision)].

.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32872711     DOI： 10.3760/cma.j.cn112140-20200422-00421

Source DB:  PubMed          Journal:  Zhonghua Er Ke Za Zhi        ISSN： 0578-1310


× No keyword cloud information.
  3 in total

1.  Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial.

Authors:  Si-Yuan Lin; Lan He; Li-Ping Xie; Yin Wang; Yi-Xiang Lin; Yin-Yin Cao; Wei-Li Yan; Fang Liu; Guo-Ying Huang
Journal:  Trials       Date:  2021-12-11       Impact factor: 2.279

2.  Giant bilateral axillary artery aneurysms with left complete obstructive thrombus in intravenous immunoglobulin-sensitive Kawasaki disease: a case report.

Authors:  Chen Chu; Lan He; Yi-Xiang Lin; Li-Ping Xie; Fang Liu
Journal:  Pediatr Rheumatol Online J       Date:  2021-11-08       Impact factor: 3.054

3.  Predictive Role of IL-2R and IL-10 in the Anti-inflammatory Response and Antiplatelet Therapy of Kawasaki Disease: A Retrospective Study.

Authors:  Chun Zhang; Lun Chen; Sun Chen; Yan Bian; Jia Shen; Peng Zhang; JiaNi Song
Journal:  Mediators Inflamm       Date:  2022-02-03       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.